 | • レポートコード：MRC2102QY12116 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：材料、化学 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の組換え非グリコシル化タンパク質市場について種類別（インスリン、rHGH、インターフェロン）、用途別（腫瘍、造血系疾患）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・組換え非グリコシル化タンパク質市場の概要 ・世界の主要地域別組換え非グリコシル化タンパク質市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の組換え非グリコシル化タンパク質市場規模2015-2026：種類別（インスリン、rHGH、インターフェロン） ・世界の組換え非グリコシル化タンパク質市場規模2015-2026：用途別（腫瘍、造血系疾患） ・組換え非グリコシル化タンパク質の米国市場規模2015-2020 ・組換え非グリコシル化タンパク質のヨーロッパ市場規模2015-2020 ・組換え非グリコシル化タンパク質の中国市場規模2015-2020 ・組換え非グリコシル化タンパク質の日本市場規模2015-2020 ・組換え非グリコシル化タンパク質の東南アジア市場規模2015-2020 ・組換え非グリコシル化タンパク質のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・組換え非グリコシル化タンパク質の製造コスト分析 ・販売チャネル、流通業者、顧客 ・組換え非グリコシル化タンパク質の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Recombinant Non-glycosylated Protein Market
The global Recombinant Non-glycosylated Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Recombinant Non-glycosylated Protein Scope and Market Size
The global Recombinant Non-glycosylated Protein market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Non-glycosylated Protein market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Recombinant Non-glycosylated Protein market is segmented into
Insulin
rHGH
Interferon
Segment by Application, the Recombinant Non-glycosylated Protein market is segmented into
Oncology
Blood Disorder
The Recombinant Non-glycosylated Protein market is analysed and market size information is provided by regions (countries). Segment by Application, the Recombinant Non-glycosylated Protein market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Recombinant Non-glycosylated Protein Market Share Analysis
Recombinant Non-glycosylated Protein market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Recombinant Non-glycosylated Protein business, the date to enter into the Recombinant Non-glycosylated Protein market, Recombinant Non-glycosylated Protein product introduction, recent developments, etc.
The major vendors covered:
Pfizer Inc
Sandoz International GmbH
Teva Pharmaceuticals Industries Ltd
Amgen Inc
Biocon Ltd
Dr.Reddy’s Laboratories Ltd
Roche Ltd
Celltrion Inc
Samsung Bioepis
1 Recombinant Non-glycosylated Protein Market Overview
1.1 Recombinant Non-glycosylated Protein Product Scope
1.2 Recombinant Non-glycosylated Protein Segment by Type
1.2.1 Global Recombinant Non-glycosylated Protein Sales by Type (2020-2026)
1.2.2 Insulin
1.2.3 rHGH
1.2.4 Interferon
1.3 Recombinant Non-glycosylated Protein Segment by Application
1.3.1 Global Recombinant Non-glycosylated Protein Sales Comparison by Application (2020-2026)
1.3.2 Oncology
1.3.3 Blood Disorder
1.4 Recombinant Non-glycosylated Protein Market Estimates and Forecasts (2015-2026)
1.4.1 Global Recombinant Non-glycosylated Protein Sales Growth Rate (2015-2026)
1.4.2 Global Recombinant Non-glycosylated Protein Revenue and Growth Rate (2015-2026)
1.4.3 Global Recombinant Non-glycosylated Protein Price Trends (2015-2026)
2 Recombinant Non-glycosylated Protein Estimate and Forecast by Region
2.1 Global Recombinant Non-glycosylated Protein Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Recombinant Non-glycosylated Protein Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Recombinant Non-glycosylated Protein Sales Market Share by Region (2015-2020)
2.2.2 Global Recombinant Non-glycosylated Protein Revenue Market Share by Region (2015-2020)
2.3 Global Recombinant Non-glycosylated Protein Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Recombinant Non-glycosylated Protein Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Recombinant Non-glycosylated Protein Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Recombinant Non-glycosylated Protein Estimates and Projections (2015-2026)
2.4.2 Europe Recombinant Non-glycosylated Protein Estimates and Projections (2015-2026)
2.4.3 China Recombinant Non-glycosylated Protein Estimates and Projections (2015-2026)
2.4.4 Japan Recombinant Non-glycosylated Protein Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Recombinant Non-glycosylated Protein Estimates and Projections (2015-2026)
2.4.6 India Recombinant Non-glycosylated Protein Estimates and Projections (2015-2026)
3 Global Recombinant Non-glycosylated Protein Competition Landscape by Players
3.1 Global Top Recombinant Non-glycosylated Protein Players by Sales (2015-2020)
3.2 Global Top Recombinant Non-glycosylated Protein Players by Revenue (2015-2020)
3.3 Global Recombinant Non-glycosylated Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Non-glycosylated Protein as of 2019)
3.4 Global Recombinant Non-glycosylated Protein Average Price by Company (2015-2020)
3.5 Manufacturers Recombinant Non-glycosylated Protein Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Recombinant Non-glycosylated Protein Players (Opinion Leaders)
4 Global Recombinant Non-glycosylated Protein Market Size by Type
4.1 Global Recombinant Non-glycosylated Protein Historic Market Review by Type (2015-2020)
4.1.1 Global Recombinant Non-glycosylated Protein Sales Market Share by Type (2015-2020)
4.1.2 Global Recombinant Non-glycosylated Protein Revenue Market Share by Type (2015-2020)
4.1.3 Global Recombinant Non-glycosylated Protein Price by Type (2015-2020)
4.2 Global Recombinant Non-glycosylated Protein Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Recombinant Non-glycosylated Protein Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Non-glycosylated Protein Revenue Forecast by Type (2021-2026)
4.2.3 Global Recombinant Non-glycosylated Protein Price Forecast by Type (2021-2026)
5 Global Recombinant Non-glycosylated Protein Market Size by Application
5.1 Global Recombinant Non-glycosylated Protein Historic Market Review by Application (2015-2020)
5.1.1 Global Recombinant Non-glycosylated Protein Sales Market Share by Application (2015-2020)
5.1.2 Global Recombinant Non-glycosylated Protein Revenue Market Share by Application (2015-2020)
5.1.3 Global Recombinant Non-glycosylated Protein Price by Application (2015-2020)
5.2 Global Recombinant Non-glycosylated Protein Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Recombinant Non-glycosylated Protein Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Non-glycosylated Protein Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Non-glycosylated Protein Price Forecast by Application (2021-2026)
6 United States Recombinant Non-glycosylated Protein Market Facts & Figures
6.1 United States Recombinant Non-glycosylated Protein Sales Market Share by Company (2015-2020)
6.2 United States Recombinant Non-glycosylated Protein Sales Market Share by Type (2015-2020)
6.3 United States Recombinant Non-glycosylated Protein Sales Market Share by Application (2015-2020)
7 Europe Recombinant Non-glycosylated Protein Market Facts & Figures
7.1 Europe Recombinant Non-glycosylated Protein Sales Market Share by Company (2015-2020)
7.2 Europe Recombinant Non-glycosylated Protein Sales Market Share by Type (2015-2020)
7.3 Europe Recombinant Non-glycosylated Protein Sales Market Share by Application (2015-2020)
8 China Recombinant Non-glycosylated Protein Market Facts & Figures
8.1 China Recombinant Non-glycosylated Protein Sales Market Share by Company (2015-2020)
8.2 China Recombinant Non-glycosylated Protein Sales Market Share by Type (2015-2020)
8.3 China Recombinant Non-glycosylated Protein Sales Market Share by Application (2015-2020)
9 Japan Recombinant Non-glycosylated Protein Market Facts & Figures
9.1 Japan Recombinant Non-glycosylated Protein Sales Market Share by Company (3015-3030)
9.2 Japan Recombinant Non-glycosylated Protein Sales Market Share by Type (2015-2020)
9.3 Japan Recombinant Non-glycosylated Protein Sales Market Share by Application (2015-2020)
10 Southeast Asia Recombinant Non-glycosylated Protein Market Facts & Figures
10.1 Southeast Asia Recombinant Non-glycosylated Protein Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Recombinant Non-glycosylated Protein Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Recombinant Non-glycosylated Protein Sales Market Share by Application (2015-2020)
11 India Recombinant Non-glycosylated Protein Market Facts & Figures
11.1 India Recombinant Non-glycosylated Protein Sales Market Share by Company (2015-2020)
11.2 India Recombinant Non-glycosylated Protein Sales Market Share by Type (2015-2020)
11.3 India Recombinant Non-glycosylated Protein Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Recombinant Non-glycosylated Protein Business
12.1 Pfizer Inc
12.1.1 Pfizer Inc Corporation Information
12.1.2 Pfizer Inc Business Overview
12.1.3 Pfizer Inc Recombinant Non-glycosylated Protein Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Inc Recombinant Non-glycosylated Protein Products Offered
12.1.5 Pfizer Inc Recent Development
12.2 Sandoz International GmbH
12.2.1 Sandoz International GmbH Corporation Information
12.2.2 Sandoz International GmbH Business Overview
12.2.3 Sandoz International GmbH Recombinant Non-glycosylated Protein Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sandoz International GmbH Recombinant Non-glycosylated Protein Products Offered
12.2.5 Sandoz International GmbH Recent Development
12.3 Teva Pharmaceuticals Industries Ltd
12.3.1 Teva Pharmaceuticals Industries Ltd Corporation Information
12.3.2 Teva Pharmaceuticals Industries Ltd Business Overview
12.3.3 Teva Pharmaceuticals Industries Ltd Recombinant Non-glycosylated Protein Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Teva Pharmaceuticals Industries Ltd Recombinant Non-glycosylated Protein Products Offered
12.3.5 Teva Pharmaceuticals Industries Ltd Recent Development
12.4 Amgen Inc
12.4.1 Amgen Inc Corporation Information
12.4.2 Amgen Inc Business Overview
12.4.3 Amgen Inc Recombinant Non-glycosylated Protein Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Amgen Inc Recombinant Non-glycosylated Protein Products Offered
12.4.5 Amgen Inc Recent Development
12.5 Biocon Ltd
12.5.1 Biocon Ltd Corporation Information
12.5.2 Biocon Ltd Business Overview
12.5.3 Biocon Ltd Recombinant Non-glycosylated Protein Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Biocon Ltd Recombinant Non-glycosylated Protein Products Offered
12.5.5 Biocon Ltd Recent Development
12.6 Dr.Reddy’s Laboratories Ltd
12.6.1 Dr.Reddy’s Laboratories Ltd Corporation Information
12.6.2 Dr.Reddy’s Laboratories Ltd Business Overview
12.6.3 Dr.Reddy’s Laboratories Ltd Recombinant Non-glycosylated Protein Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Dr.Reddy’s Laboratories Ltd Recombinant Non-glycosylated Protein Products Offered
12.6.5 Dr.Reddy’s Laboratories Ltd Recent Development
12.7 Roche Ltd
12.7.1 Roche Ltd Corporation Information
12.7.2 Roche Ltd Business Overview
12.7.3 Roche Ltd Recombinant Non-glycosylated Protein Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Roche Ltd Recombinant Non-glycosylated Protein Products Offered
12.7.5 Roche Ltd Recent Development
12.8 Celltrion Inc
12.8.1 Celltrion Inc Corporation Information
12.8.2 Celltrion Inc Business Overview
12.8.3 Celltrion Inc Recombinant Non-glycosylated Protein Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Celltrion Inc Recombinant Non-glycosylated Protein Products Offered
12.8.5 Celltrion Inc Recent Development
12.9 Samsung Bioepis
12.9.1 Samsung Bioepis Corporation Information
12.9.2 Samsung Bioepis Business Overview
12.9.3 Samsung Bioepis Recombinant Non-glycosylated Protein Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Samsung Bioepis Recombinant Non-glycosylated Protein Products Offered
12.9.5 Samsung Bioepis Recent Development
13 Recombinant Non-glycosylated Protein Manufacturing Cost Analysis
13.1 Recombinant Non-glycosylated Protein Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Recombinant Non-glycosylated Protein
13.4 Recombinant Non-glycosylated Protein Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Recombinant Non-glycosylated Protein Distributors List
14.3 Recombinant Non-glycosylated Protein Customers
15 Market Dynamics
15.1 Recombinant Non-glycosylated Protein Market Trends
15.2 Recombinant Non-glycosylated Protein Opportunities and Drivers
15.3 Recombinant Non-glycosylated Protein Market Challenges
15.4 Recombinant Non-glycosylated Protein Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Recombinant Non-glycosylated Protein Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Recombinant Non-glycosylated Protein Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Recombinant Non-glycosylated Protein Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Recombinant Non-glycosylated Protein Sales (K MT) by Region (2015-2020)
Table 5. Global Recombinant Non-glycosylated Protein Sales Market Share by Region (2015-2020)
Table 6. Global Recombinant Non-glycosylated Protein Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Recombinant Non-glycosylated Protein Revenue Share by Region (2015-2020)
Table 8. Global Recombinant Non-glycosylated Protein Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Recombinant Non-glycosylated Protein Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Recombinant Non-glycosylated Protein Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Recombinant Non-glycosylated Protein Revenue Share Forecast by Region (2021-2026)
Table 12. Global Recombinant Non-glycosylated Protein (K MT) of Key Companies (2015-2020)
Table 13. Global Recombinant Non-glycosylated Protein Sales Share by Company (2015-2020)
Table 14. Global Recombinant Non-glycosylated Protein Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Recombinant Non-glycosylated Protein Revenue Share by Company (2015-2020)
Table 16. Global Recombinant Non-glycosylated Protein by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Non-glycosylated Protein as of 2019)
Table 17. Global Recombinant Non-glycosylated Protein Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Recombinant Non-glycosylated Protein Manufacturing Sites and Area Served
Table 19. Manufacturers Recombinant Non-glycosylated Protein Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Recombinant Non-glycosylated Protein Players
Table 22. Global Recombinant Non-glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 23. Global Recombinant Non-glycosylated Protein Sales Share by Type (2015-2020)
Table 24. Global Recombinant Non-glycosylated Protein Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Recombinant Non-glycosylated Protein Price (K MT) by Type (2015-2020)
Table 26. Global Recombinant Non-glycosylated Protein Sales Share by Type (2021-2026)
Table 27. Global Recombinant Non-glycosylated Protein Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Recombinant Non-glycosylated Protein Revenue Share by Type (2021-2026)
Table 29. Global Recombinant Non-glycosylated Protein Price (K MT) by Type (2021-2026)
Table 30. Global Recombinant Non-glycosylated Protein Sales (K MT) by Application (2015-2020)
Table 31. Global Recombinant Non-glycosylated Protein Sales Share by Application (2015-2020)
Table 32. Global Recombinant Non-glycosylated Protein Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Recombinant Non-glycosylated Protein Price (K MT) by Application (2015-2020)
Table 34. Global Recombinant Non-glycosylated Protein Sales (K MT) by Application (2021-2026)
Table 35. Global Recombinant Non-glycosylated Protein Sales Share by Application (2021-2026)
Table 36. Global Recombinant Non-glycosylated Protein Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Recombinant Non-glycosylated Protein Revenue Share by Application (2021-2026)
Table 38. Global Recombinant Non-glycosylated Protein Price (K MT) by Application (2021-2026)
Table 39. United States Recombinant Non-glycosylated Protein Sales (K MT) by Company (2015-2020)
Table 40. United States Recombinant Non-glycosylated Protein Sales Market Share by Company (2015-2020)
Table 41. United States Recombinant Non-glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 42. United States Recombinant Non-glycosylated Protein Sales Market Share by Type (2015-2020)
Table 43. United States Recombinant Non-glycosylated Protein Sales (K MT) by Application (2015-2020)
Table 44. United States Recombinant Non-glycosylated Protein Sales Market Share by Application (2015-2020)
Table 45. Europe Recombinant Non-glycosylated Protein Sales (K MT) by Company (2015-2020)
Table 46. Europe Recombinant Non-glycosylated Protein Sales Market Share by Company (2015-2020)
Table 47. Europe Recombinant Non-glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 48. Europe Recombinant Non-glycosylated Protein Sales Market Share by Type (2015-2020)
Table 49. Europe Recombinant Non-glycosylated Protein Sales (K MT) by Application (2015-2020)
Table 50. Europe Recombinant Non-glycosylated Protein Sales Market Share by Type (2015-2020)
Table 51. China Recombinant Non-glycosylated Protein Sales (K MT) by Company (2015-2020)
Table 52. China Recombinant Non-glycosylated Protein Sales Market Share by Company (2015-2020)
Table 53. China Recombinant Non-glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 54. China Recombinant Non-glycosylated Protein Sales Market Share by Type (2015-2020)
Table 55. China Recombinant Non-glycosylated Protein Sales (K MT) by Application (2015-2020)
Table 56. China Recombinant Non-glycosylated Protein Sales Market Share by Application (2015-2020)
Table 57. Japan Recombinant Non-glycosylated Protein Sales (K MT) by Company (2015-2020)
Table 58. Japan Recombinant Non-glycosylated Protein Sales Market Share by Company (2015-2020)
Table 59. Japan Recombinant Non-glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 60. Japan Recombinant Non-glycosylated Protein Sales Market Share by Type (2015-2020)
Table 61. Japan Recombinant Non-glycosylated Protein Sales (K MT) by Application (2015-2020)
Table 62. Japan Recombinant Non-glycosylated Protein Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Recombinant Non-glycosylated Protein Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Recombinant Non-glycosylated Protein Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Recombinant Non-glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Recombinant Non-glycosylated Protein Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Recombinant Non-glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Recombinant Non-glycosylated Protein Sales Market Share by Application (2015-2020)
Table 69. India Recombinant Non-glycosylated Protein Sales (K MT) by Company (2015-2020)
Table 70. India Recombinant Non-glycosylated Protein Sales Market Share by Company (2015-2020)
Table 71. India Recombinant Non-glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 72. India Recombinant Non-glycosylated Protein Sales Market Share by Type (2015-2020)
Table 73. India Recombinant Non-glycosylated Protein Sales (K MT) by Application (2015-2020)
Table 74. India Recombinant Non-glycosylated Protein Sales Market Share by Application (2015-2020)
Table 75. Pfizer Inc Corporation Information
Table 76. Pfizer Inc Description and Business Overview
Table 77. Pfizer Inc Recombinant Non-glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Pfizer Inc Recombinant Non-glycosylated Protein Product
Table 79. Pfizer Inc Recent Development
Table 80. Sandoz International GmbH Corporation Information
Table 81. Sandoz International GmbH Description and Business Overview
Table 82. Sandoz International GmbH Recombinant Non-glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Sandoz International GmbH Recombinant Non-glycosylated Protein Product
Table 84. Sandoz International GmbH Recent Development
Table 85. Teva Pharmaceuticals Industries Ltd Corporation Information
Table 86. Teva Pharmaceuticals Industries Ltd Description and Business Overview
Table 87. Teva Pharmaceuticals Industries Ltd Recombinant Non-glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Teva Pharmaceuticals Industries Ltd Recombinant Non-glycosylated Protein Product
Table 89. Teva Pharmaceuticals Industries Ltd Recent Development
Table 90. Amgen Inc Corporation Information
Table 91. Amgen Inc Description and Business Overview
Table 92. Amgen Inc Recombinant Non-glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Amgen Inc Recombinant Non-glycosylated Protein Product
Table 94. Amgen Inc Recent Development
Table 95. Biocon Ltd Corporation Information
Table 96. Biocon Ltd Description and Business Overview
Table 97. Biocon Ltd Recombinant Non-glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Biocon Ltd Recombinant Non-glycosylated Protein Product
Table 99. Biocon Ltd Recent Development
Table 100. Dr.Reddy's Laboratories Ltd Corporation Information
Table 101. Dr.Reddy's Laboratories Ltd Description and Business Overview
Table 102. Dr.Reddy's Laboratories Ltd Recombinant Non-glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Dr.Reddy's Laboratories Ltd Recombinant Non-glycosylated Protein Product
Table 104. Dr.Reddy's Laboratories Ltd Recent Development
Table 105. Roche Ltd Corporation Information
Table 106. Roche Ltd Description and Business Overview
Table 107. Roche Ltd Recombinant Non-glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Roche Ltd Recombinant Non-glycosylated Protein Product
Table 109. Roche Ltd Recent Development
Table 110. Celltrion Inc Corporation Information
Table 111. Celltrion Inc Recombinant Non-glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Celltrion Inc Description and Business Overview
Table 113. Celltrion Inc Recombinant Non-glycosylated Protein Product
Table 114. Celltrion Inc Recent Development
Table 115. Samsung Bioepis Corporation Information
Table 116. Samsung Bioepis Recombinant Non-glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Samsung Bioepis Description and Business Overview
Table 118. Samsung Bioepis Recombinant Non-glycosylated Protein Product
Table 119. Samsung Bioepis Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Recombinant Non-glycosylated Protein Distributors List
Table 123. Recombinant Non-glycosylated Protein Customers List
Table 124. Recombinant Non-glycosylated Protein Market Key Trends
Table 125. Recombinant Non-glycosylated Protein Key Opportunities and Drivers
Table 126. Recombinant Non-glycosylated Protein Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Non-glycosylated Protein Product Picture
Figure 2. Global Recombinant Non-glycosylated Protein Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Recombinant Non-glycosylated Protein Market Share by Application in 2020 & 2026
Figure 6. Oncology Examples
Figure 7. Blood Disorder Examples
Figure 8. Global Recombinant Non-glycosylated Protein Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Recombinant Non-glycosylated Protein Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Recombinant Non-glycosylated Protein Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Recombinant Non-glycosylated Protein Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Recombinant Non-glycosylated Protein Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Recombinant Non-glycosylated Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Recombinant Non-glycosylated Protein Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Recombinant Non-glycosylated Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Recombinant Non-glycosylated Protein Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Recombinant Non-glycosylated Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Recombinant Non-glycosylated Protein Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Recombinant Non-glycosylated Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Recombinant Non-glycosylated Protein Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Recombinant Non-glycosylated Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Recombinant Non-glycosylated Protein Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Recombinant Non-glycosylated Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Recombinant Non-glycosylated Protein Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Recombinant Non-glycosylated Protein Players Market Share by Revenue in Recombinant Non-glycosylated Protein 2015 & 2019
Figure 26. Recombinant Non-glycosylated Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Recombinant Non-glycosylated Protein Revenue Share by Type (2015-2020)
Figure 28. Global Recombinant Non-glycosylated Protein Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Recombinant Non-glycosylated Protein Revenue Share by Application (2015-2020)
Figure 30. Global Recombinant Non-glycosylated Protein Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Recombinant Non-glycosylated Protein Sales Market Share by Type in 2019
Figure 32. United States Recombinant Non-glycosylated Protein Sales Market Share by Type in 2019
Figure 33. Europe Recombinant Non-glycosylated Protein Sales Market Share by Company in 2019
Figure 34. Europe Recombinant Non-glycosylated Protein Sales Market Share by Type in 2019
Figure 35. Europe Recombinant Non-glycosylated Protein Sales Market Share by Application in 2019
Figure 36. China Recombinant Non-glycosylated Protein Sales Market Share by Company in 2019
Figure 37. China Recombinant Non-glycosylated Protein Sales Market Share by Type in 2019
Figure 38. China Recombinant Non-glycosylated Protein Sales Market Share by Application in 2019
Figure 39. Japan Recombinant Non-glycosylated Protein Sales Market Share by Company in 2019
Figure 40. Japan Recombinant Non-glycosylated Protein Sales Market Share by Type in 2019
Figure 41. Japan Recombinant Non-glycosylated Protein Sales Market Share by Application in 2019
Figure 42. Southeast Asia Recombinant Non-glycosylated Protein Sales Market Share by Company in 2019
Figure 43. Southeast Asia Recombinant Non-glycosylated Protein Sales Market Share by Type in 2019
Figure 44. Southeast Asia Recombinant Non-glycosylated Protein Sales Market Share by Application in 2019
Figure 45. India Recombinant Non-glycosylated Protein Sales Market Share by Company in 2019
Figure 46. India Recombinant Non-glycosylated Protein Sales Market Share by Type in 2019
Figure 47. India Recombinant Non-glycosylated Protein Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Recombinant Non-glycosylated Protein
Figure 50. Manufacturing Process Analysis of Recombinant Non-glycosylated Protein
Figure 51. Recombinant Non-glycosylated Protein Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
組換えグリコシル化タンパク質の世界市場レポート2020 Market Analysis and Insights: Global Recombinant Glycosylated Protein Market The global Recombinant Glycosylated Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Recombinant Glycosylated Protein Scope and Market …- 治療用組換えタンパク質の世界市場レポート2020 Recombinant Therapeutic Protein are produced by using a technique called recombinant DNA or recombinant RNA to produce proteins. The method can be divided into in vitro method and in vivo method. Both approaches are premised on the use of genetic recombination techniques to obtain recombinant vector…
- 組換えトリプシンの世界市場レポート2020 Market Analysis and Insights: Global Recombinant Trypsin Market The global Recombinant Trypsin market size is projected to reach US$ 44 million by 2026, from US$ 27 million in 2020, at a CAGR of 8.2% during 2021-2026. Global Recombinant Trypsin Scope and Market Size The global Recombinant Trypsin ma…
- 組換えヒトエンドスタチンの世界市場レポート2020 Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162−302 and Cys264−294. Market Analysis and Insights: Global Recombinant Human Endostatin Market The global Recombinan…
- 組換えヒト血清アルブミンの世界市場レポート2020 Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression syste…